GRAND RAPIDS, Mich., Sept. 8, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that it has entered into a settlement agreement with Catalyst OrthoScience Inc. ("Catalyst") to resolve all outstanding patent litigation between the two companies. The terms of the settlement agreement are confidential.

"We are pleased to have reached a resolution with Catalyst that provides an agreeable solution to this patent dispute," said Rob Ball, CEO of Shoulder Innovations. "Protecting our intellectual property is fundamental to ensuring that the investments we make in innovation continue to benefit Shoulder Innovations stakeholders, particularly including surgeons and patients. We believe this outcome enables us to continue to deliver on what matters most – advancing shoulder arthroplasty and delivering the best possible outcomes for patients."

About Shoulder Innovations

Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations' ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations' ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact

Brian Johnston or Sam Bentzinger

Gilmartin Group LLC

[email protected]

SOURCE Shoulder Innovations

Share this article

LANGHORNE, Pa., Sept. 8, 2026 /PRNewswire/ -- TEN Holdings, Inc. (Nasdaq: XHLD) ("TEN Holdings" or the "Company"), through its subsidiary, Ten Events, Inc., a technology platform for enterprise-grade webcasts and virtual events, today announced the Company's participation in the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14-16, 2026 at the Lotte New York Palace Hotel in New York City.

The H.C. Wainwright Annual Global Investment Conference is a premier event that brings together corporate leaders, institutional investors, and industry experts from around the world to explore emerging trends, investment opportunities, and strategic insights across a wide range of sectors, including Life Sciences, FinTech, Metals & Mining, Technology/Media/Telecom & Growth, and Cleantech. The conference features company presentations, one-on-one investor meetings, and keynote addresses. Held annually in New York City, the conference has become a key destination for global investors seeking to discover high-growth potential companies. Learn more about the event at https://hcwevents.com/annualconference.

TEN Holdings' Chairman and Chief Executive Officer, Virgilio Torres, is scheduled to deliver a live company presentation at the conference and will be available for one-on-one meetings with investors throughout the event.

Investors interested in scheduling a meeting with TEN Holdings' management team should contact their H.C. Wainwright representative or email [email protected].

"We're in the middle of executing the growth strategy we outlined for shareholders earlier this year, and H.C. Wainwright gives us a direct line to the investors who want to track that progress," said Virgilio Torres, Chairman and Chief Executive Officer of TEN Holdings, Inc. "We look forward to discussing the momentum we're building with our platform, the capital priorities we're executing against, and where we see this Company heading as we scale."

About TEN Holdings, Inc.

TEN Holdings, Inc. (Nasdaq: XHLD) is a technology company for enterprise-grade virtual events, offering a self-service platform through its subsidiary, Ten Events, Inc., that scales to over 100,000 concurrent attendees at 99.99% uptime. The Company is backed by more than a decade of experience producing mission-critical corporate broadcasts for Fortune 500 clients, and its roadmap extends this foundation with AI-driven capabilities in analytics, captioning, and intent data. Headquartered in Pennsylvania, TEN Holdings produces virtual, hybrid, and physical events supported by its Ten Events platform. To learn more, visit www.tenholdingsinc.com.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, but not limited to, statements regarding the Company's growth strategy and participation in industry conferences, and the uncertainties related to market conditions and other factors discussed in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the "SEC") and other filings with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and TEN Holdings, Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

For more information, please contact:

Investor Relations Inquiries:

Skyline Corporate Communications Group, LLC

Scott Powell, President

1177 Avenue of the Americas, 5th Floor

New York, New York 10036

Office: (646) 893-5835

Email: [email protected]

SOURCE TEN Holdings, Inc.

Share this article

SAN DIEGO, Sept. 8, 2026 /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today declared an increase in its common stock monthly cash dividend to $0.2715 per share from $0.2710 per share. The dividend is payable on October 15, 2026, to stockholders of record as of September 30, 2026. The new monthly dividend represents an annualized dividend amount of $3.258 per share as compared to the prior annualized dividend amount of $3.252 per share.

"Today's announcement marks the 136th dividend increase since Realty Income's listing on the New York Stock Exchange in 1994," said Sumit Roy, Realty Income's President and Chief Executive Officer. "The consistency of our dividend is rooted in the strength of our platform, the diversification of our portfolio, and our disciplined approach to capital allocation. These attributes have enabled us to generate reliable cash flows through a variety of market environments and allowed us to continue delivering long-term value to our shareholders."

About Realty Income

Realty Income (NYSE: O), an S&P 500 company, is real estate partner to the world's leading companies®. Founded in 1969, we serve our clients as a full-service real estate capital provider. As of June 30, 2026, we have a portfolio of over 15,500 properties in all 50 U.S. states, the U.K., and eight other countries in Europe. We are known as "The Monthly Dividend Company®" and have a mission to invest in people and places to deliver dependable monthly dividends that increase over time. Since our founding, we have declared 675 consecutive monthly dividends and are a member of the S&P 500 Dividend Aristocrats® index for having increased our dividend for over 31 consecutive years. Additional information about the company can be found at www.realtyincome.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. When used in this press release, the words "estimate," "anticipate," "assume," "expect," "believe," "intend," "continue," "should," "may," "likely," "plan," "seek," and similar expressions are intended to identify forward-looking statements. Forward-looking statements include discussions of our business, strategy, portfolio, platform, plans, and the intentions of management including dividends and the amount, timing and payment thereof. Forward-looking statements are subject to risks, uncertainties, and assumptions about us which may cause our actual future results to differ materially from expected results. Some of the factors that could cause actual results to differ materially are, among others, our continued qualification as a real estate investment trust; general domestic and foreign business, economic, or financial conditions; competition; fluctuating interest and currency rates; inflation and its impact on our clients and us; access to debt and equity capital markets and other sources of funding (including the terms, structure and partners of such funding); volatility and uncertainty in the credit and financial markets; other risks inherent in real estate, private capital, credit and mezzanine investments, and joint ventures or co-investment ventures, including solvency, defaults under leases, bankruptcies, potential liability relating to environmental matters, illiquidity of real estate investments (including rights of first refusal or rights of first offer), and potential damages from natural disasters; impairments in the value of our real estate assets; volatility and changes in domestic and foreign laws and the application, enforcement or interpretation thereof (including with respect to tax laws and rates); property ownership through co-investment ventures, funds, joint ventures, partnerships and other arrangements which, among other things, may transfer or limit our control of the underlying investments; epidemics or pandemics; the loss of key personnel; the threat and outcome of any legal proceedings to which we are a party or which may occur in the future; acts of terrorism and war; and the anticipated benefits from mergers, acquisitions, co-investment ventures, funds, joint ventures, partnerships, and other arrangements; and those additional risks and factors discussed in our reports filed with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are not guarantees of future plans and performance and speak only as of the date of this press release. Past operating results and performance are provided for informational purposes and are not a guarantee of future results. There can be no assurance that historical trends will continue. Actual plans and results may differ materially from what is expressed or forecasted in this press release and forecasts made in the forward-looking statements discussed in this press release might not materialize. We do not undertake any obligation to update forward-looking statements or publicly release the results of any forward-looking statements that may be made to reflect events or circumstances after the date these statements were made or to reflect the occurrence of unanticipated events.

SOURCE Realty Income Corporation

Share this article

CARLSBAD, Calif., Sept. 8, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor conference:

Cantor Global Healthcare Conference 2026

Format: Virtual fireside chat and one-on-one investor meetings

Presentation Date/Time: Wednesday, September 9, 2026 at 1:00 PM ET

Location: New York, NY

A live webcast of the presentation can be accessed by visiting the "For Investors" page on the Tyra Biosciences website and will be available for replay following the event.

About Tyra Biosciences

Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help TYRA design and predict which candidates may demonstrate the highest potency, selectivity and tolerability in the clinic. TYRA's expertise in FGFR biology has created a differentiated pipeline with clinical-stage programs in targeted oncology and genetically defined conditions. TYRA's lead precision medicine stemming from SNÅP, oral dabogratinib, is a potential first-in-class selective FGFR3 inhibitor in development for low-grade upper tract urothelial carcinoma, low-grade intermediate-risk non-muscle invasive bladder cancer and achondroplasia. TYRA is also developing TYRA-430, an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers, in the SURF431 study for advanced hepatocellular carcinoma, and TYRA-200, an oral, investigational FGFR1/2/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma. TYRA is based in Carlsbad, California.

For more information, please visit www.tyra.bio and engage with TYRA on LinkedIn.

Contact

Amy Conrad

[email protected]

SOURCE Tyra Biosciences

Share this article

NEW YORK, Sept. 8, 2026 /PRNewswire/ --

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blaize Holdings, Inc. (NASDAQ: BZAI) between July 18, 2025 and April 28, 2026, both dates inclusive (the "Class Period"), of the important October 5, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.

So what: If you purchased Blaize securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

What to do next: To join the Blaize class action, go to https://rosenlegal.com/cases/blaize-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 5, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Why Rosen Law: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered billions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

Details of the case: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Blaize announced transactions with entities wholly unequipped to conduct meaningful business in order to create an appearance of growth; (2) Blaize improperly recognized revenue; and (3) as a result, defendants' public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Blaize class action, go to https://rosenlegal.com/cases/blaize-holdings-inc/join or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

     Laurence Rosen, Esq.

     Phillip Kim, Esq.

     The Rosen Law Firm, P.A.

     275 Madison Avenue, 40th Floor

     New York, NY 10016

     Tel: (212) 686-1060

     Toll Free: (866) 767-3653

     Fax: (212) 202-3827

     [email protected] 

     www.rosenlegal.com

SOURCE THE ROSEN LAW FIRM, P. A.

Share this article

Industry veteran brings more than 20 years of fenestration and building materials experience to support strategic customer relationships and business growth

EXPORT, Pa., Sept. 8, 2026 /PRNewswire/ -- FlexScreen® / RiteScreen®, a leading manufacturer of innovative window and door screen solutions, announced today that David Whisenhunt has joined the company as Director of Sales.

In his new role, Whisenhunt will focus on new business development and building strategic partnerships with key and national accounts. He will work closely with customers to identify new opportunities, strengthen relationships, and support the continued growth of FlexScreen® / RiteScreen®.

Whisenhunt brings more than 20 years of experience in the fenestration and building materials industry. Throughout his career, he has held leadership and sales roles with ColorCoat, Quanex, Milgard Windows & Doors, and Cascade Windows. His experience includes developing strategic partnerships, growing sales, and bringing innovative products and solutions to the window and door industry.

"David brings extensive industry knowledge, strong relationships, and a proven track record of developing strategic business," said Mark Gwozdz, Vice President of Strategic Partnerships at FlexScreen® / RiteScreen®. "His experience and understanding of the fenestration market will be a valuable addition as we continue to strengthen our customer partnerships and identify new opportunities for growth."

"David understands this industry, but more importantly, he understands the importance of building strong, long-term relationships with customers," said Joe Altieri, Founder of FlexScreen®. "As we continue bringing FlexScreen and RiteScreen together and looking at where we can grow, having someone with David's experience and relationships on our team is a tremendous asset. I'm excited to see what he brings to our customers and our organization."

Whisenhunt holds a Master of Science from the University of Southern California and a Bachelor of Science from the University of San Francisco.

Whisenhunt officially joined FlexScreen® / RiteScreen® on September 8, 2026.

About FlexScreen® / RiteScreen®

FlexScreen® / RiteScreen® provides innovative window and door screen solutions to manufacturers and customers across North America and beyond. By combining FlexScreen's patented flexible window screen technology with RiteScreen's extensive manufacturing capabilities and industry experience, the unified organization offers a broad portfolio of screen products backed by a nationwide manufacturing footprint.

RiteScreen has been owned and supported by Seven Point Equity Partners since 2014, with FlexScreen joining the Seven Point portfolio in 2025.

For more information, visit FlexScreenRiteScreen.com.

About Seven Point Equity Partners

Seven Point is a private investment firm founded by Tom Burchill and Mark Kammert and based in Miami. Seven Point pursues a value-oriented and operationally-focused investment strategy, investing where it can use its expertise and resources to fundamentally transform businesses and deliver exceptional returns for investors. The firm's investment interest is focused on specialty manufacturing and business services in industry sectors that are expected to grow faster than the U.S. economy.

SOURCE FlexScreen

Share this article

HANOVER, Pa., Sept. 8, 2026 /PRNewswire/ -- Hanover Foods Corp. announced today it has launched a new Skinny Veg® frozen vegetable product line to serve the growing market of consumers using GLP-1 weight-loss medications.

The Skinny Veg® product line includes four frozen blended vegetable and grain sides, each with just five simple ingredients: one vegetable, one grain or legume, avocado oil, pepper and sea salt.

The Skinny Veg® products include:

- Skinny Veg® Broccoli & Quinoa

- Skinny Veg® Brussels Sprouts & Couscous

- Skinny Veg® Spinach & Blackeye Peas

- Skinny Veg® Riced Cauliflower & Lentils

"We believe the ingredient list should be the least surprising part of your meal, which is why Skinny Veg is intentionally simple," said Hanover Foods CEO Jeff Warehime. "Our Skinny Veg sides have just five simple ingredients. No additives or preservatives. Just real food for real people."

"We know consumers are looking for smart, healthy options that pack a flavorful punch," Warehime said. "With our Skinny Veg products, Hanover Foods offers a healthy option from a trusted source. For more than 100 years, we have been a family-owned company that is committed to producing quality foods made with care and delivered with excellence, from seed to fork. That's our mission."

Hanover Foods launched its Skinny Veg® products in select stores in August and expects to expand distribution to its full retail network in early 2027. For more information on Hanover Foods' Skinny Veg® products, visit HanoverFoods.com/Skinny-Veg.

ABOUT HANOVER FOODS CORP.

Founded in 1924, Hanover Foods is one of the largest family-owned food companies in the United States, producing a wide range of products – from its well-known canned vegetables, beans, and chili to freshly prepared foods, flash frozen foods, and wholesome snack food items. The company includes Aunt Kitty's Foods, Bickel's Snack Foods, Spring Glen Fresh Foods and Alcosa. Hanover Foods operates 12 locations across the United States and Guatemala and employs approximately 3,000 people. Visit HanoverFoods.com. 

SOURCE Hanover Foods Corp.

Share this article

Moonshot AI, the autonomous website optimization platform, becomes Shuttlebase after an unexpected name collision creates confusion.

NEW YORK, Sept. 8, 2026 /PRNewswire/ -- Founded in 2023 by Aviv Frenkel and Evyatar Segal, Moonshot AI previously operated under its name when the China-based Moonshot AI, behind the Kimi AI models, began its global expansion, creating a mix-up between the two unrelated businesses.

Because of the confusion, Moonshot AI is now Shuttlebase, marking a new chapter for the New York-based company.

"We didn't plan on changing our name, but the collision forced us to think about what we're actually building," said Aviv Frenkel, Co-Founder and CEO. "Shuttlebase captures that vision. We want to build the launchpad that allows eCommerce brands to continuously improve and move faster."

Behind the rebrand is a company tackling a fundamental problem in eCommerce. Brands spend heavily driving traffic to their sites, but improving what happens after a shopper arrives still requires a full team to manually test and optimize.

Unlike traditional experimentation platforms, Shuttlebase is an autonomous optimization system for eCommerce websites. It analyzes how shoppers move through a site, identifies opportunities, designs and codes the change, tests it against live traffic, and deploys the winner. Then it starts again.

"What we've built is not a smarter A/B testing tool," said Evyatar Segal, Co-Founder and CTO. "It's a system that understands a website and how visitors interact with it, identifies the opportunities most likely to make an impact, and actually builds and tests the change."

The platform is trained on millions of real conversions. Each experiment informs future optimization, allowing Shuttlebase to learn from patterns across its network.

Shuttlebase has generated millions in measurable revenue uplift for brands including Credo Beauty, DefenAge, Kopari, Peter Thomas Roth, and P&G's Farmacy Beauty.

Early results include:

- DefenAge: +30% revenue per visitor and +14% conversion rate

- Alembika: $114,000 from a single experiment and +10.5% purchase conversion

Shuttlebase has raised $10 million from Mighty Capital, Oceans Ventures, Uncorrelated, Garuda Ventures, and Almaz Capital.

"The next generation of eCommerce won't be built around teams manually running a handful of tests every quarter," said Frenkel. "It will be built around systems that are constantly learning, experimenting, and improving."

Shuttlebase is headquartered in New York City.

To learn more, visit shuttlebase.com

SOURCE Shuttlebase

Share this article

LOS ANGELES, Sept. 8, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Wise Group plc.

IF YOU SUFFERED A LOSS ON YOUR WISE GROUP PLC INVESTMENTS, CLICK HERE BEFORE SEPTEMBER 29, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT

What Is The Lawsuit About? 

The complaint filed in this class action alleges that between May 11, 2026 and July 23, 2026, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) in order to have a successful debut on the NASDAQ, defendants materially understated Wises regulatory risks as a result of its materially deficient anti-money laundering efforts, as well as insufficient efforts to prevent the financing of terrorism; and (2) as a result, defendants statements about Wise's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

What's The Next Step?

Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist you in potentially pursuing claims to recover your loss.

If you wish to serve as lead plaintiff, you must move the Court no later than September 29, 2026. Please contact us to learn more about your rights and interests by clicking here, by email ([email protected]), or by telephone at 310-201-9150 (Toll-Free: 888-773-9224).

You may retain counsel of your choice. If you bought securities during the class period, you may take no action and remain an absent class member. No class has been certified yet.

Why Glancy Prongay Wolke & Rotter LLP? 

GPWR is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Recognizing the firm's recent successes, GPWR was named one of Law360's Securities Groups of the Year and ranked 2nd in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. GPWR's lawyers have handled cases covering a wide spectrum of corporate misconduct and relating to nearly all industries and sectors. GPWR's past successes have been widely covered by leading news and industry publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money. Prior results do not guarantee a similar outcome.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact Us: 

Glancy Prongay Wolke & Rotter LLP,  

1925 Century Park East, Suite 2100,

Los Angeles, CA 90067

Charles Linehan

Email:  [email protected]

Telephone: 310-201-9150

Toll-Free: 888-773-9224

Visit our website at: www.glancylaw.com.

SOURCE Glancy Prongay Wolke & Rotter LLP

Share this article

The article outlines how to recognize early symptoms and why timely care supports long-term oral health.

FAIRPORT, N.Y. , Sept. 8, 2026 /PRNewswire/ -- What are the early signs of gum disease that people should watch for? HelloNation has published an article that provides clear answers, featuring insights from Dental Expert Dr. Marian Burgard of Fairport Family Dental.

The HelloNation article explains that gum disease often begins with subtle symptoms that many people overlook. Early warning signs such as bleeding gums during brushing or flossing, swollen gums, and mild tenderness can signal the start of inflammation. The article notes that these symptoms may appear even in individuals who maintain a daily oral hygiene routine, underscoring the importance of awareness for early detection.

According to the article, bleeding gums are one of the most common early indicators of gum disease. This occurs when plaque builds up along the gum line, allowing bacteria to irritate sensitive tissue. Swollen gums may also develop as the body responds to this irritation. The article emphasizes that pain is not always present in early stages, which can cause people in Fairport and Rochester, NY, to delay seeking care.

The article describes how consistent oral hygiene habits play a key role in preventing gum disease from progressing. Brushing twice daily with fluoride toothpaste and flossing regularly helps remove plaque from hard-to-reach areas. Maintaining strong oral hygiene practices reduces the likelihood of developing swollen gums or persistent bleeding gums over time.

In addition to daily care, the HelloNation article highlights the importance of routine dental checkups. Regular dental checkups allow Dental Experts to identify early signs of gum disease before they worsen. Professional cleanings remove hardened plaque and tartar that cannot be addressed through home care alone. Patients in Fairport and Rochester NY, are encouraged to schedule dental checkups consistently to monitor gum health.

The article also explains that untreated gum disease can advance into periodontitis, a more serious condition that may lead to tooth loss and broader health concerns. Periodontitis develops when inflammation spreads below the gum line, damaging supporting bone and tissue. Recognizing early symptoms, such as bleeding or swollen gums, can help prevent this progression and reduce the need for more complex treatment.

Lifestyle factors are another important consideration discussed in the article. Smoking, poor nutrition, and unmanaged health conditions such as diabetes can increase the risk of gum disease. The article notes that combining strong oral hygiene habits with healthy lifestyle choices can significantly lower the chances of developing periodontitis.

The HelloNation article emphasizes that early action is the most effective way to manage gum disease. Addressing symptoms like bleeding gums or swollen gums early often involves simple treatments and improved oral hygiene, rather than invasive procedures. Dental Experts recommend that individuals in Fairport and Rochester, NY, pay close attention to small changes and seek care promptly.

By understanding the early signs and maintaining regular dental checkups, patients can protect their oral health and avoid complications. The article reinforces that awareness, prevention, and professional care work together to keep gum disease under control and support long-term wellness.

What Are the Early Signs of Gum Disease People Should Watch For? features insights from Dr. Marian Burgard, Dental Expert of Fairport, New York, in HelloNation.

About HelloNation

HelloNation is America's Good News Network, a premier media platform built on the idea that good news travels faster when real people tell real stories. Through its community-focused publications and innovative “edvertising” approach, HelloNation delivers content that informs, inspires, and spotlights the leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article